Summary
This prediction ended on 14.08.26 with a price of €2.50. The price of Altimmune has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.30%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Altimmune | -1.331% | -1.331% | -16.236% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
Comments by UBS_Group_AG for this prediction
In the thread Altimmune diskutieren
Altimmune, Inc. (NASDAQ: ALT) had its price target lowered by analysts at UBS Group AG from $26.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for ALT provided by MarketBeat
In the thread Trading Altimmune
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten